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Abstract Postmortem imaging is increasingly used in fo-
rensic practice in cases of natural deaths related to cardio-
vascular diseases, which represent the most common causes
of death in developed countries. While radiological exami-
nation is generally considered to be a good complement for
conventional autopsy, it was thought to have limited appli-
cation in cardiovascular pathology. At present, multidetector
computed tomography (MDCT), CT angiography, and
cardiac magnetic resonance imaging (MRI) are used in
postmortem radiological investigation of cardiovascular pa-
thologies. This review presents the actual state of postmor-
tem imaging for cardiovascular pathologies in cases of
sudden cardiac death (SCD), taking into consideration both
the advantages and limitations. The radiological evaluation
of ischemic heart disease (IHD), the most frequent cause of
SCD in the general population of industrialized countries,
includes the examination of the coronary arteries and myo-
cardium. Postmortem CT angiography (PMCTA) is very use-
ful for the detection of stenoses and occlusions of coronary
arteries but less so for the identification of ischemic
myocardium. MRI is the method of choice for the radiological
investigation of the myocardium in clinical practice, but its
accessibility and application are still limited in postmortem
practice. There are very few reports implicating postmortem
radiology in the investigation of other causes of SCD, such as
cardiomyopathies, coronary artery abnormalities, and valvular
pathologies. Cardiomyopathies representing the most frequent
cause of SCD in young athletes cannot be diagnosed by
echocardiography, the most widely available technique in
clinical practice for the functional evaluation of the heart and
the detection of cardiomyopathies. PMCTA andMRI have the
potential to detect advanced stages of diseases when morpho-
logical substrate is present, but these methods have yet to be
sufficiently validated for postmortem cases. Genetically de-
termined channelopathies cannot be detected radiologically.
This review underlines the need to establish the role of post-
mortem radiology in the diagnosis of SCD.
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Introduction
Radiological postmortem examination for cardiovascular
pathologies
Radiological imaging plays a very important role in the
diagnosis of cardiac pathologies in the living. In forensic
postmortem practice, radiological examination has proven
to be a very useful tool for cases such as gunshot wounds,
physical child abuse, and victim identification. In the last
15 years, computed tomography and magnetic resonance
imaging (CT and MRI) have been increasingly used in
routine forensic practice and research. Undetermined causes
of death and sudden cardiac deaths (SCD) represent an
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important part of forensic practice and these cases are in-
creasingly investigated with modern radiological techni-
ques. Radiological postmortem examination was initially
considered to be of limited benefit and low accuracy for
the investigation of cardiovascular pathologies [1]. The
introduction of postmortem CT angiography (PMCTA),
which enables the investigation of the vascular lumen, has
proven to be very promising [2–7] and the first postmortem
MRI (PMMR) studies have yielded interesting results for
the investigation of ischemic myocardium [8, 9]. The goal
of this paper is to discuss the advantages and limitations of
postmortem imaging for the diagnosis of cardiac patholo-
gies in SCD.
Sudden cardiac death
Although definitions of sudden death and SCD vary greatly,
the most widely accepted definition of SCD is a sudden and
unexpected death that occurs within 1 h of symptom onset.
For unwitnessed deaths, victims observed alive within 24 h
before death meet the definition [10, 11]. The underlying
cause of sudden death is most frequently cardiovascular in
origin, with ischemic heart disease (IHD) being most common
in the general population [11].
Any sudden, unexpected, or unexplained death war-
rants medicolegal investigation. SCD autopsies should
be performed according to guidelines set by the fields
of forensic medicine and cardiovascular pathology. Clas-
sical investigation of SCD includes the evaluation of clin-
ical history, autopsy, and histology examination and
sometimes the analysis of cardiac biomarkers and/or genetic
analyses for channelopathies. No gold standards currently
exist for the postmortem radiological evaluation of cardiovas-
cular pathologies.
Epidemiology and causes of sudden cardiac death
Cardiovascular pathologies are the most common causes
of death in developed countries. In recent prospective
studies using multiple sources in the United States, the
Netherlands, Ireland, and China, SCD rates range from
50 to 100 per 100,000 in the general population [12, 13].
The true incidence of SCD remains unknown and is likely
under-reported, since sudden arrhythmic events are often mis-
classified as drowning, traffic traumas, or epileptic seizures
[14, 15]. The most common clinical finding associated with
SCD in the general population is IHD. According to epidemi-
ological studies, approximately 80 % of SCD cases can be
attributed to this disease. Ten to fifteen percent of SCDs result
from cardiomyopathies with a morphological substrate, such
as hypertrophic cardiomyopathy (HCM), arrhythmogenic
right ventricular cardiomyopathy/dysplasia (ARVC/D), and
myocardial infiltrative diseases (i.e., sarcoidosis). In the
remaining 5–10 %, the cause of SCD is related to either a
structurally abnormal congenital cardiac condition (i.e.,
coronary artery abnormalities) or to cardiac channelopathies
[11].
The causes and incidences of SCD in younger individ-
uals vary according to the study and population. The major
limitation of SCD evaluation is the lack of adequate or
available autopsies. In the Irish study comprising 116 vic-
tims between 14 and 35 years of age, the most frequent
causes of death were sudden unexplained death syndrome
(26.7 %), coronary artery disease (20.7 %), HCM (14.7 %),
and idiopathic left ventricular hypertrophy not fulfilling
criteria for HCM (10.3 %) [16]. In a recent retrospective
study, Eckart et al. reviewed 902 nontraumatic sudden
deaths in individuals with a mean age of 38±11 years.
They showed that in those <35 years of age, the leading
cause of death was sudden unexplained death (41.3 %),
whereas in those ≥35 years of age, the leading cause of
death was atherosclerotic coronary artery disease (73.2 %)
[17].
Sports-related SCD or SCD in athletes fall into a separate
group. Mass media has focused a lot of attention on young
athletes who die suddenly while training or during compe-
tition. Such deaths illustrate that vigorous exertion can tran-
siently increase the risk of SCD and highlights the paradox
that physical activity can have both a positive and a negative
impact on an individual’s health. The reported causes of
SCD among athletes differ between studies, with a high
proportion due to HCM in the United States [18] and due
to ARVC in Italy [19]. A Danish study performed in 2010
reported the incidence rate of SCD in competitive athletes to
be higher than that of the general population. The most
common autopsy findings were ARVC, sudden unexplained
death, and coronary artery disease [20].
Ischemic heart disease
IHD related to atherosclerotic disease and impaired cardiac
blood supply continues to be the most frequent cause of
death in the general population in industrialized countries
[11]. IHD refers to a group of clinicopathological condi-
tions, which include angina pectoris (stable or unstable),
acute myocardial infarction, chronic IHD with or without
heart failure, and SCD. Plaque rupture is the primary under-
lying cause of luminal thrombosis, responsible for provok-
ing acute coronary syndromes such as myocardial infarction
and SCD. The secondary mechanism, more frequent in
younger individuals, is related to plaque erosion [21]. In-
stant death due to ventricular fibrillation or atrioventricular
block is a frequent complication of coronary thrombosis and
is responsible for 50 % of acute myocardial infarction mor-
tality [22]. Chronic IHD can be deemed the cause of death if
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at least one of the main coronary arteries has a narrowing of
75 % or more and complimentary analyses (i.e., toxicology
and clinical chemistry) are negative. Also, nonatheroscler-
otic coronary artery diseases can provoke ischemic events.
These diseases include late stage of obliterative intimal
thickening, coronary artery dissection, ostial stenosis, coro-
nary arteritis and aneurysm, coronary emboli, coronary ar-
tery spasm, and myocardial bridging.
In clinical practice, the diagnosis of IHD is largely based
on the presence or absence of specific symptoms. The
diagnostic gold standards are electrocardiography and car-
diac biomarkers. Stress testing and/or angiography are often
used to identify and treat coronary artery disease. Invasive
coronary angiography is currently the “gold standard” for
assessing coronary artery stenosis [5]. It can be used as a
rule-out test in patients with low to intermediate likelihood
of disease, as shown by Schlattmann et al. in a recent
metaregression analysis [23]. Cardiac multidetector CT
(MDCT), including contrast-enhanced MDCT coronary an-
giography, is considered to be a powerful diagnostic tool for
the assessment of coronary disease in acute and chronic
cases [3]. CT angiography is the method of choice for the
assessment of both the arterial lumen and wall disease. CT
angiography has also proven to be useful for the assessment
of the degree of myocardial perfusion and the detection of
any previous infarctions with the measurement of myocar-
dial attenuation using Hounsfield units. Decreased perfusion
is associated with reduced myocardial enhancement. In ad-
dition, old infarctions show lower CT attenuation than re-
cent ones [24]. Cardiac MRI is a reference standard for the
assessment of ventricular function and may help identify
and classify scars for risk stratification [25].
The biggest clinical challenge is the detection of patients
with vulnerable plaques that are subject to either plaque
rupture or erosion. Even the combination of imaging tech-
niques fails to accurately pinpoint vulnerable plaques. It is
recognized that coronary CT angiography can detect two
important features of coronary plaque vulnerability: a large,
soft plaque and focal vascular remodeling [26]. Other mor-
phological characteristics of a vulnerable plaque, such as
thin cap fibroatheroma and a lipid core, can be identified
with angioscopy, high frequency intravascular ultrasound,
intravascular MRI, and optical coherence tomography. Ac-
tive inflammation in high-risk plaques can be detected using
intravascular thermography [27]. Coronary artery calcifica-
tions, detectable by CT but not MRI imaging, are considered
to be predictors of a cardiovascular event and plaque bur-
den. There are, however, controversial opinions concerning
the role of calcium, especially since some studies have
suggested that it may be protective against the development
of acute coronary syndrome [28].
The postmortem investigation of IHD is different than in
classical clinical practice as it is impossible to use certain
techniques, such as electrocardiography and many of the
laboratory analyses, after death. The postmortem diagnosis
of IHD is based on the evaluation of the coronary arteries
and myocardium. The postmortem angiographical examina-
tion of coronary arteries was initially performed in 1899,
3 years after the discovery of X-rays [29]. At present,
coronary arteries are investigated using PMCT/PMCTA
[2–4, 6] and/or PMMR/PMMRA [30, 31].
A recent study performed on 23 forensic cases showed
that PMCT is of limited diagnostic value for IHD. PMCTA,
if correctly interpreted, is a reasonable tool to view the
morphology of coronary arteries, rule out significant coro-
nary artery stenosis, identify occlusions, and direct sampling
for histological examination. Radiological examination by
PMCT or PMCTA enables the detection and documentation
of coronary artery calcification better than classical autopsy.
However, the visualization and differentiation of PMCT
artifacts has yet to be studied [3].
PMMR examination of ischemic myocardium was first
performed on eight autopsy cases in 2006 by Jackowski et
al. They demonstrated that PMMR enables the detection of
myocardial infarction in situ and the estimation of infarct
age based on signal behavior [9]. A few authors have
recently reported on the PMMR-based diagnosis of coro-
nary artery disease-related deaths [8, 30, 31]. Although the
presence of a clot is highly indicative for a coronary event,
PMMR cannot certainly differentiate between postmortem
clots and vital thromboses.
PMCTA and PMMR have both their advantages and
disadvantages for the postmortem examination of IHD. Al-
though MRI is the method of choice for the radiological
investigation of the myocardium (Fig. S1), the biggest ad-
vantage of PMCTA is its ability to investigate the vessel’s
lumen, enabling the detection of stenoses and occlusions
(Fig. 1). Both methods are associated with a risk of thrombi
dislodgement, and they do not enable the differentiation
between vital and artifactual postmortem thrombi. Radio-
logical techniques using injected agents are very useful for
the detection of coronary stenoses and occlusions, but the
diagnosis must be confirmed visually and/or histologically
in order to rule out postmortem artifact. The biggest disad-
vantages of both postmortem techniques are that they re-
quire dedicated and expensive technical equipment as well
as physicians experienced in the fields of postmortem radi-
ology and cardiovascular pathology.
Cardiomyopathies
In 2006, the expert consensus defined cardiomyopathies as an
important and heterogeneous group of myocardial diseases
associated with mechanical and/or electrical dysfunction, usu-
ally exhibiting inappropriate ventricular hypertrophy or
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dilatation due to a variety of causes that frequently are
genetic. Cardiomyopathies are either confined to the heart or
are part of generalized systemic disorders, often leading to
cardiovascular death or progressive heart failure-related
disabilities [32]. The most frequently involved cardiomyop-
athies in SCD, especially in young individuals, are HCM
and ARVC.
In the clinical setting, echocardiography is the most com-
monly used tool for the detection of cardiomyopathies and
the functional evaluation of the heart. MRI is becoming
increasingly important, as it can acquire high-resolution
images of the heart in any desired plane [33]. MRI can
better differentiate tissue properties, is noninvasive, and
has a higher resolution. Clinical MRI also has the potential
to detect regional and diastolic ventricular dysfunctions,
which can represent early manifestations of ARVC. The
current imaging tools cannot determine the aetiology of
the cardiomyopathy, which is essential for both treatment
and prognosis [34].
Hypertrophic cardiomyopathy/athlete’s heart
HCM is the most common genetic cardiac disease, with a
prevalence of 1:500 in the general population. HCM is an
autosomal dominant disease caused by mutations in genes
encoding sarcomere proteins. It is also one of the most com-
mon causes of SCD in young individuals and young athletes.
In the clinical setting, HCM is defined by unexplained left
ventricular hypertrophy without dilation of the ventricu-
lar chambers, in the absence of any other cardiac or
systemic disease that could explain the hypertrophy.
Clinically, HCM is usually characterized by a left ventricle
wall thickness ≥15 mm, with 13 to 14 mm considered as
borderline [35].
HCM has a diverse phenotypic expression, ranging from
a silent disease to very severe one. Imaging plays a key role
in the diagnosis of HCM; transthoracic echocardiography
remains the gold standard for the screening and initial eval-
uation of HCM [35]. Cardiac MRI is indicated in patients
with suspected HCM when echocardiography is inconclusive
or when additional information may have an impact on further
management. Additional imaging techniques, including coro-
nary angiography (invasive or CT imaging) and positron
emission tomography, may be indicated depending on the
clinical picture.
HCM must be differentiated from hypertensive heart
disease and physiological remodeling in athletes, as athletic
hearts and secondary causes of hypertrophy (i.e., hyperten-
sion and aortic stenosis) may mimic HCM. It is well recog-
nized that the border between physiological and
pathological changes is poorly defined [10]. Cardiac MRI
is very useful to show different enhancement patterns via
late gadolinium enhancement in some forms of cardiac
hypertrophy (cardiac amyloidosis, sarcoidosis, and Fabry)
[36]. The histological examination is necessary to detect
constellation of hypertrophy, fibrosis and small vessel dis-
ease and myocyte disarray. These findings represent the
gold standard for the pathological confirmation of the
HCM diagnosis [37]. The combination of noninvasive car-
diac imaging and genetic screening will further aid in the
Fig. 1 Coronary artery
thrombosis observed in PMCTA
of a 47-year-old man who died
suddenly: while the native
PMCT shows only a small calci-
fication of the left intraventricu-
lar coronary artery (arrow in a),
the arterial phase of the PMCTA
(b) reveals a significant stenosis
(arrow in b). A 3D volume
rendering reconstruction (c)
clearly demonstrates the stenosis
and its exact localization
(arrow). Histological examina-
tion in H&E-stained section (d)
of the concerned part of the ar-
tery shows advanced fibro lipid
eccentric plaque and thrombotic
material in the lumen
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preclinical diagnosis and management of patients with
HCM [36].
No postmortem radiological observations have been
reported for HCM, but PMMR alone or in conjunction with
PMCTA should be considered, as previously suggested by
Jackowski et al. [38]. PMCT and PMCTA allow the obser-
vation of global cardiac hypertrophy (Fig. S2), which might
have, however, many possible aetiologies. At present, au-
topsy and histological examination remain the gold stand-
ards for the postmortem diagnosis of HCM.
Arrhythmogenic right ventricular cardiomyopathy
ARVC/D is a genetically determined heart muscle disorder
characterized by structural and functional abnormalities,
mostly of the right ventricle resulting from progressive,
fibrofatty replacement of the right ventricular myocardium
starting from the epicardium. The left ventricle is occasion-
ally involved as well. Fibrofatty replacement leads to wall
thinning and aneurysm formation, typically located at the
inferior, apical, and infundibular walls. Its estimated preva-
lence is between 1:1,000 and 1:5,000 in the general popu-
lation [39, 40]. The presence of fatty tissue in the right
ventricular free wall is of limited diagnostic specificity as
it is a common finding in normal hearts, particularly in
obese and elderly individuals.
The clinical diagnosis of ARVC is currently based on the
presence of different standardized task force criteria as right
ventricular functional and structural changes, electrocardio-
graphical depolarization and repolarization abnormalities,
ventricular arrhythmias, fibrofatty replacement of the myo-
cardium, and a positive family history. The diagnosis can be
established when different diagnostic criteria are present. An
accurate postmortem diagnosis of ARVC is important for
any surviving family members, as it is a hereditary disease
and there are available treatment options for the prevention
of sudden death [39, 40].
In patients with structurally severe disease, all cardiac
imaging methods are likely to yield abnormal findings.
Echocardiography is most often the first imaging method
used for the assessment of index cases and family members,
since it is widely available and noninvasive. CTangiography
is very helpful for the detection of akinetic or dyskinetic
bulging in the triangle of dysplasia. MRI is a powerful imag-
ing method due to its greater ability for tissue characterization.
While in morphologically severe forms, MRI does not add to
diagnosis, MRI with gadolinium enhancement has the
potential to detect regional and diastolic ventricular
dysfunctions, most likely related to intramyocardial fibrosis,
which can be an early manifestation of ARVC. Therefore,
MRI is able to detect early stages and subtle cases.
The detection of fatty infiltration is not sufficient for the
diagnosis of the disease, as it may present in healthy adults
and patients with other myocardial diseases [41]. Consider-
ing that coronary artery disease is a common cause of left
ventricular dilation and dysfunction that can mimic ARVC,
this pathology should be excluded. MDCT coronary angi-
ography has shown a negative predictive value of 100 % in
excluding significant CAD in patients with ARVC [24].
No comparative studies have been performed to evaluate
the radiological aspects of ARVC in the postmortem setting.
Jackowski et al. reported a case with fatty infiltration of the
free right ventricular wall and thinning of the apical right
ventricular wall visualized by PMMR, which was suggestive
of ARVC [38]. It is possible to detect some radiological
features of ARVC with PMCTA, such as fatty infiltration
and right ventricular dilation (Fig. 2). However, considering
the guidelines for the clinical diagnosis and given the impor-
tance of the diagnosis for the next of kin, both the autopsy and
histological examination remain the gold standards for the
postmortem diagnosis.
Channelopathies
Progress made in the fields of molecular biology and human
genetics have resulted in the identification of the genetic
origin of many cardiac diseases, which can lead to both
structural (e.g., HCM) and arrhythmogenic abnormalities
(e.g., long QT syndrome and Brugada syndrome) that can
result in SCD. Autopsy-negative SCD are most often thought
to be the result of sudden arrhythmic death syndrome. Sudden
arrhythmic death syndrome cannot be detected with any of the
aforementioned imaging techniques.
Cardiac sarcoidosis/myocarditis
Sarcoidosis is a multisystem granulomatous disease of an
unknown aetiology, characterized by noncaseating granulo-
mas in involved organs. The incidence of sarcoidosis varies
with race. The prevalence is 10–40/100,000 persons in the
United States and Europe, with an increased prevalence in
African-Americans [42].
In clinical practice, the imaging methods used to evaluate
sarcoidosis are echocardiography, nuclear medicine, and
more recently, gadolinium-enhanced cardiac MRI [34]. In
the postmortem setting, PMMR and PMCT may prove to be
useful for the establishment of the diagnosis and to direct
sampling for histological examination, but no reports have
been published to date (Fig. 3).
Myocarditis is an acute or chronic inflammatory disease
of the myocardium, characterized by myocardial inflamma-
tory infiltrates with myocyte degeneration and necrosis. In
current clinical practice, myocardial biopsy is essential for
diagnosis [43, 44]. Echocardiography and cardiac MRI are
likely to become the noninvasive standard radiological
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examinations for the investigation of myocarditis and to
assist in the performance of guided biopsies from the areas
of marked contrast enhancement [45, 46].
There are currently no reports on the postmortem radiolog-
ical imaging of myocarditis. The precise mapping of inflam-
matory myocardial lesions with cardiac MRI might increase
the diagnostic yield of guided myocardial sampling, but the
accessibility ofMRI remains limited in the postmortem setting.
Valvular abnormalities
Although rare in the general population, aortic stenosis and
mitral valve prolapse are the most frequently reported valvu-
lopathies to cause SCD in young individuals. In clinical prac-
tice, aortic valvular disease can be satisfactorily studied with
Doppler echocardiography, whereas coronary angiography
can be technically difficult and may increase potential risks
[24]. PMCTand PMCTA enable the visualization of calcifica-
tion in aortic stenosis (Fig. S3) butmitral valve prolapse cannot
be detected with postmortem radiological imaging as it is
mainly a functional disorder. It is even difficult or impossible
to prove its role in causing death with an autopsy examination.
Coronary artery anomalies
Coronary anomalies occur in <1 % of the general population
and can range from a benign incidental finding to the cause
of SCD [47, 48]. Classic coronary anomalies include those
Fig. 2 An 18-year-old athletic
man who died suddenly while
doing sport: PMCTA (a and b)
showed the dilation of the right
ventricle, a fatty aspect of the
ventricular wall (arrows in a)
and increased trabecularization
of the right ventricle. Conven-
tional autopsy confirmed these
findings, especially the presence
of fatty infiltration in the right
ventricular wall (arrows in c).
Histological examination (d and
e) allowed the classical diagnosis
of ARVC concerning the right
ventricle and the posterior wall
of the left ventricle (Masson
trichrome stain)
Fig. 3 Multiorganic sarcoidosis involving the heart of a 35-year-old
man who died suddenly while cycling. In PMCT (a), nodular forma-
tions in the lungs (arrow in a) were observed that aroused the suspicion
of sarcoidosis as well as a massive pulmonary oedema centered on the
hilum indicating cardiac failure. Histological examination of the myo-
cardium showed typical multiple lymphatic foci, sarcoid giant cells
embedded in a fibrous background without surrounding necrosis, in-
volving both ventricles and the ventricular septum (H&E staining)
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in which a coronary artery originates from the contralateral
aortic sinus or the pulmonary artery with an anomalous
course [49, 50].
Although invasive angiography has historically been used to
diagnose coronary anomalies, MDCT imaging techniques are
now an accurate noninvasive alternative [50, 51]. Coronary CT
angiography provides detailed visualization of complex coro-
nary artery anatomy and is currently the method of choice for
the detection and classification of coronary artery anomalies
[48]. MDCTA is considered to be superior to conventional
angiography in delineating the ostial origin and proximal course
of anomalous coronary arteries. In patients with myocardial
bridging who present with chest pain or even myocardial in-
farction, MDCTA has the advantage of assessing the coronary
artery lumen as well as the surrounding myocardium [24].
In the postmortem setting, PMCTA allows for excellent
visualization of coronary artery anatomy (Fig. 4). Okura et
al. presented a case report of SCD with a calcified coronary
artery aneurysm related to Kawasaki disease that was visu-
alized by PMCTA imaging [52].
Sudden postoperative deaths
Sudden deaths can also occur in patients undergoing cardio-
vascular surgery. MDCT angiography allows for the nonin-
vasive evaluation of coronary bypass graft patency with a
high diagnostic accuracy [53, 54]. MDCTA is a reliable
noninvasive diagnostic method that can clearly display the
stent lumen and is especially helpful for patient follow-up.
This technique can be used to evaluate the full range of
stent-related problems, such as stent thrombosis, jailed
branches, edge stenosis, bifurcation stents, inadequate stent
expansion, and stent aneurysms [55].
In the postmortem examination, PMCT allows for the
detection of coronary stents and artificial heart valves,
which can be difficult to visualize in the presence of severe
calcifications. PMCTA can demonstrate the permeability of
coronary bypass and can help guide autopsy dissection
technique (Fig. 5). In occluded bypass grafts, classical dis-
section is necessary to rule out postmortem artifact.
Discussion
The clinical diagnostic approach for cardiovascular pathol-
ogies is different than that involved in postmortem forensic
investigations. The clinician takes into account the anamne-
sis, clinical examination, electrocardiogram readings,
radiological examination, and measurement of cardiac bio-
markers, to name a few. Many clinical diagnostic tools are
useful for assessing function and are of limited value in the
postmortem setting. On the other hand, the autopsy renders
a detailed visual assessment and histological examinations
of the myocardium easily accessible. The importance of
establishing a diagnosis is also different. In living patients,
the clinical diagnosis is essential for both treatment and
prognosis; in forensic practice, determining the cause of
death can direct the juridical investigations. An autopsy
diagnosis for genetically determined cardiac pathologies is
also essential for the prevention of sudden death in living
family members.
The radiological cardiac examination differs in the pre-
and postmortem settings. In the living, the radiological
cardiac examination is aimed at the evaluation of structure
and function. Cardiac physiology, filling pressures, and
valvular function can be assessed in detail by Doppler
echocardiography [24]. The functional assessment is impos-
sible after death, and the imaging techniques are limited to
structural evaluations. Most postmortem imaging findings
are confirmed at autopsy, in order to rule out postmortem
artifacts [56]. Advanced decomposition can destroy organ
structure and gas-related artifacts should be carefully ana-
lyzed [57]. That being said, postmortem radiology has many
advantages. The major advantage of postmortem radiologi-
cal examination is that the artifacts related to heartbeats, for
example, are not present. Radiation exposure is not a con-
cern and allows for the acquisition of high-quality images.
There are no motion-related artifacts. Some specific exami-
nations, such as CT coronary angiography, may be contra-
indicated in the living due to the risk of an allergic response
and/or the impairment of renal function, which are not an
issue in the postmortem setting.
The contribution of postmortem radiological imaging tech-
niques is increasing in cardiovascular pathology, but there is
currently no consensus on the role of the postmortem radio-
logical examination in autopsy diagnosis, especially for
Fig. 4 Morphologies of coronary arteries visualized by PMCTA. a
Coronary arteries in a 33-year-old man who collapsed in a night club,
just after complaining about thoracic pain; electrocardiogram showed
ventricular fibrillation. Reconstruction of PMCTA images allows the
visualization of a variant of coronary arteries with the circumflex artery
(arrow) originating from the right sinus. b Another variant of coronary
arteries: trifurcation of the left coronary artery in a 58-year-old man
found dead at his home. The cause of death was attributed to an acute
bronchopneumonia
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cardiovascular pathologies resulting in SCD. Cardiovascular
pathologies present particular diagnostic challenges, both in
the clinical and postmortem settings. The guidelines for the
clinical radiological examination have been established by
many experts [35, 40, 58]. Often the radiological examination
alone is unable to diagnose many of the hereditary cardiac
diseases, such as ARVC, HCM, and channelopathies. The
validity of radiological postmortem findings, without confir-
mation by classical autopsy, is not yet known. Most publica-
tions are based on very few observations and the results have
yet to be independently verified. In this paper, we presented
the state of the art for the radiological examination of cardio-
vascular pathologies. In postmortem imaging, cardiovascular
pathologies have been analyzed by only a few groups [3, 4,
6–8, 29]. While PMCTA allows for the morphological evalu-
ation of coronary arteries and the detection of suspected ste-
noses and occlusions, PMMR provides superior soft tissue
visualization [3, 4, 6, 8, 29, 59]. Postmortem imaging techni-
ques, especially those associated with the intravascular injec-
tion of contrast, are able to demonstrate and document a
number of cardiovascular pathologies, but some hereditary
cardiac diseases, such as ARVC, HCM, and channelopathies,
cannot be diagnosed with these techniques.
The need to establish the diagnostic value of postmortem
radiology as well as its degree of certitude has been suggested
by many authors. In 2012, Roberts et al. published a study
undertaken at two UK centers between 2006 and 2008. They
investigated 182 adult deaths that underwent whole-body CT,
MRI, and a full autopsy. They concluded that when compared
with traditional autopsy, PMCTwas a more accurate imaging
technique than PMMR for establishing a cause of death. The
most common misdiagnosis when using postmortem imaging
was IHD, which represents the most common cause of death
in the general population. The authors underline the potential
risk of systematic errors inmortality statistics that would result
if imaging were to replace conventional autopsy [59]. The
radiological degree of certitude is important, especially in the
forensic interpretation of the case. The interpretation of the
autopsy findings and the medicolegal conclusions are of great
interest for the police, investigating magistrate or prosecutor,
lawyers, and courts. The interpretation should consider all
reanimation and postmortem artifacts [56, 60]. In clinical
radiology, many artifacts have been reported [61–63]. Radio-
logical findings may also be incidental and unrelated to the
cause of death. One report stated that a variety of findings
suggestive of myocardial infarction were found on routine
chest CT in patients who may not have had a prior diagnosis
of IHD [64]. The possible artifacts of postmortem radiological
examination should be carefully studied and considered when
interpreting medicolegal cases that might involve civil or
penal responsibilities.Misinterpretations of the morphological
findings and complimentary exams can contribute to a mis-
carriage of justice. In a study published in 2012, Murken et al.
showed that the radiologic diagnoses were often discrepant
from autopsy findings and that autopsies can help radiologists
sharpen their skills and can perhaps serve as quality control
mechanisms for radiology and vice versa [65, 66].
Evaluating of the cost/benefit of autopsies was suggested
by some authors in order to consider postmortem imaging as a
complement and/or alternative to traditional clinical autopsies.
If the goal of the autopsy is to determine the cause of death, the
degree of certitude of the radiological diagnosis is very
Fig. 5 Coronary artery stent
(arrows) in native PMCT (a)
and PMCTA (b). While the
native CT scan can only
confirm the presence and
localization of the stent in the
left interventricular artery,
PMCTA proves the intact
perfusion of the stent. c
Coronary bypass between the
left internal mammary artery
and the left interventricular
artery (yellow arrow) visualized
by PMCTA, with an occlusion
of the left interventricular artery
in its middle part (black arrow).
The red arrow indicates the
right internal mammary artery
134 Int J Legal Med (2014) 128:127–137
important. If an exact cause of death is not required and if the
goal of the autopsy is to exclude traumatic deaths, some
autopsies may not be necessary. In selected cases, an external
examination would be sufficient while keeping in mind the
limitations of this examination in the interpretation of the case.
In our opinion, postmortem radiology should be performed
in cases where additional information concerning the cause of
death should be obtained or if radiological imaging may help
to document pathologies before performing the destructive
autopsy, which would allow for a future independent review.
In the field of the cardiovascular pathology, the postmortem
radiological examination is most often not sufficient to estab-
lish the exact cause of death and autopsy remains the gold
standard. More studies are needed in order to establish the
validity and limitations of the postmortem radiological assess-
ment of cardiovascular pathologies, mainly because of the
numerous postmortem artifacts. At present, there are no non-
invasive techniques that can replace histological examination.
Postmortem radiological examination, followed by a complete
autopsy, can help further the understanding and interpretation
of the radiological examination in the living. The limitations
of interpretation for the radiological postmortem examination
should be highlighted, especially in cases involving legal or
ethical responsibilities. Overinterpretation may contribute to a
miscarriage of justice or to an incorrect clinical approach
involving families of SCD victims.
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